Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Feun LG, Li YY, Wu C, Wangpaichitr M, et al. Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma. Cancer 2019 Jun 28. doi: 10.1002/cncr.32339.
PMID: 31251403


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016